DK421383A - Humant interleukin - Google Patents

Humant interleukin Download PDF

Info

Publication number
DK421383A
DK421383A DK421383A DK421383A DK421383A DK 421383 A DK421383 A DK 421383A DK 421383 A DK421383 A DK 421383A DK 421383 A DK421383 A DK 421383A DK 421383 A DK421383 A DK 421383A
Authority
DK
Denmark
Prior art keywords
interleukin
purified
humant
lymphocytes
homogeneity
Prior art date
Application number
DK421383A
Other languages
English (en)
Other versions
DK165412C (da
DK421383D0 (da
DK165412B (da
Inventor
Alvin S Stern
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK421383D0 publication Critical patent/DK421383D0/da
Publication of DK421383A publication Critical patent/DK421383A/da
Publication of DK165412B publication Critical patent/DK165412B/da
Application granted granted Critical
Publication of DK165412C publication Critical patent/DK165412C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK421383A 1982-09-16 1983-09-15 Fremgangsmaade til fremstilling af humant interleukin DK165412C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41892782 1982-09-16
US06/418,927 US4490289A (en) 1982-09-16 1982-09-16 Homogeneous human interleukin 2

Publications (4)

Publication Number Publication Date
DK421383D0 DK421383D0 (da) 1983-09-15
DK421383A true DK421383A (da) 1984-03-17
DK165412B DK165412B (da) 1992-11-23
DK165412C DK165412C (da) 1993-04-13

Family

ID=23660116

Family Applications (1)

Application Number Title Priority Date Filing Date
DK421383A DK165412C (da) 1982-09-16 1983-09-15 Fremgangsmaade til fremstilling af humant interleukin

Country Status (14)

Country Link
US (2) US4490289A (da)
EP (1) EP0106179B1 (da)
JP (1) JPS5970620A (da)
AT (1) ATE20073T1 (da)
AU (1) AU598251B2 (da)
CA (1) CA1239871A (da)
CS (1) CS395391A3 (da)
DE (1) DE3363781D1 (da)
DK (1) DK165412C (da)
IE (1) IE55920B1 (da)
IL (1) IL69731A (da)
NZ (1) NZ205593A (da)
PH (1) PH17834A (da)
ZA (1) ZA836830B (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4778879A (en) * 1982-04-20 1988-10-18 Sloan-Kettering Institute For Cancer Research Highly purified human interleukin 2 and method
US4950598A (en) * 1982-09-22 1990-08-21 The Board Of Trustees Of The Leland Stanford Junior University Process for making T cell hybridomas
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
US5700913A (en) * 1982-12-15 1997-12-23 Ajinomoto Co., Inc. Unglycosylated human interleukin-2 polypeptides
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4723000A (en) * 1983-07-05 1988-02-02 Biospectrum, Inc. Human interferon gamma and interleukin-2
WO1985000606A1 (en) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Human il-2 and process for its preparation
US4675383A (en) * 1983-11-15 1987-06-23 The Salk Institute For Biological Studies Purification of T-cell growth factor
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4696915A (en) * 1984-05-25 1987-09-29 Hoffmann-La Roche Inc. Parathymosin alpha
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4921667A (en) * 1985-04-23 1990-05-01 New York University Method for augmenting immune response
US4690893A (en) * 1985-05-03 1987-09-01 Dnax Research Institute Of Molecular And Cellular Biology, Inc. Hybridoma cell lines producing monoclonal antibodies which specifically bind to mouse interleukin-2
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
US4770781A (en) * 1986-03-03 1988-09-13 Merck & Co., Inc. Purification of human interleukin-1 species
EP0302894B1 (en) * 1986-04-28 1992-11-19 Endotronics Inc. Method of culturing leukocytes
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5034513A (en) * 1987-05-27 1991-07-23 The United States Of America As Represented By The Secretary Of Agriculture Avian interleukin-2
US5417970A (en) * 1988-10-21 1995-05-23 Sanofi Drugs containing a glycosylated interleukin-2
JPH0266086U (da) * 1988-11-07 1990-05-18
US5245016A (en) * 1991-01-31 1993-09-14 University Of Utah Research Foundation Pseudomonas maltophilia immunoglobulin binding protein and methods for its use
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP0855918A4 (en) 1995-10-17 2002-08-14 Univ Wayne State INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
EP0966523A1 (en) * 1997-01-31 1999-12-29 Hemosol Inc. Method for the production of selected lymphocytes
DK1463751T3 (da) 2001-12-21 2013-08-26 Human Genome Sciences Inc Albuminfusionsproteiner.
US20050282814A1 (en) * 2002-10-03 2005-12-22 Targegen, Inc. Vasculostatic agents and methods of use thereof
EP1549614A4 (en) * 2002-10-03 2008-04-16 Targegen Inc VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
NZ551027A (en) 2004-04-08 2011-01-28 Targegen Inc Benzotriazine inhibitors of kinases
MX2007002208A (es) 2004-08-25 2007-05-08 Targegen Inc Compuestos hetrociclicos y metodos de uso.
NZ563984A (en) * 2005-06-08 2011-11-25 Targegen Inc Methods and compositions for the treatment of ocular disorders
US8604042B2 (en) * 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
US8133900B2 (en) * 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
HUE028987T2 (en) * 2005-11-01 2017-01-30 Targegen Inc BI-aryl-meta-pyrimidine inhibitors of kinases
WO2007127366A2 (en) * 2006-04-25 2007-11-08 Targegen, Inc. Kinase inhibitors and methods of use thereof
WO2009152610A1 (en) * 2008-06-20 2009-12-23 The Royal Institution For The Advancement Of Learning/Mcgill University Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
US9332998B2 (en) 2012-08-13 2016-05-10 Covidien Lp Apparatus and methods for clot disruption and evacuation
US9332999B2 (en) 2012-08-13 2016-05-10 Covidien Lp Apparatus and methods for clot disruption and evacuation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390623A (en) * 1980-10-02 1983-06-28 Hooper Trading Company Serum-free and mitogen-free T-cell growth factor and process for making same
JPS58159420A (ja) * 1982-03-18 1983-09-21 Ajinomoto Co Inc インタ−ロイキン２の精製法
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4778879A (en) * 1982-04-20 1988-10-18 Sloan-Kettering Institute For Cancer Research Highly purified human interleukin 2 and method

Also Published As

Publication number Publication date
EP0106179A1 (de) 1984-04-25
AU1916083A (en) 1984-03-22
EP0106179B1 (de) 1986-05-28
CS395391A3 (en) 1992-09-16
ZA836830B (en) 1984-05-30
CA1239871A (en) 1988-08-02
IE832168L (en) 1984-03-16
IE55920B1 (en) 1991-02-27
IL69731A0 (en) 1983-12-30
PH17834A (en) 1985-01-07
US4490289A (en) 1984-12-25
IL69731A (en) 1988-01-31
DE3363781D1 (en) 1986-07-03
DK165412C (da) 1993-04-13
DK421383D0 (da) 1983-09-15
JPS5970620A (ja) 1984-04-21
NZ205593A (en) 1987-03-06
AU598251B2 (en) 1990-06-21
JPH0244480B2 (da) 1990-10-04
AU559677B2 (en) 1987-03-19
DK165412B (da) 1992-11-23
ATE20073T1 (de) 1986-06-15
AU7197087A (en) 1987-08-13
US5597901A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
DK421383A (da) Humant interleukin
ES2156852T3 (es) Citoquina mamifera, il-11.
DE3667946D1 (de) Tisch zum fixieren am ruecken eines sessels.
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
ATE26115T1 (de) Substituierte 8-phenylxanthine.
ATE76905T1 (de) Reinigung von rekombinanten interleukin-2.
ATE63923T1 (de) Neues derivat des humangammainterferonpolypeptids.
AU7270387A (en) Enhanced expression of human interleukin-2 in mammalian cells
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
ES8101530A1 (es) Un procedimiento para la preparacion de alcoholes beta-gama-dihidro-poliprenilicos.
IL68678A0 (en) Process for the production of interleukin and its analogous immune regulating factors and pharmaceutical formulations comprising the same
DK623188D0 (da) Fremgangsmaade til inkubation af rekombinante proteinekspressionsceller
AU555018B2 (en) Efficiency improvement of in vitro tissue cultivation
ES2052562T3 (es) Peptido antineoplasico inducido por la interleucina-2.
IT206001Z2 (it) Piastrina per composizioni varie in particolare di lampade e lampadari
ATE49164T1 (de) Tisch zum fixieren am ruecken eines sessels.
IT8248183A0 (it) Diagnostica con immonofluorescenza od immunoperossidasi su cellule di coltura infettate in vitro
DK489086A (da) Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler
YU4792A (sh) Postupak gajenja tumornih infiltirajućih limfocita
BR6401118U (pt) Quadro com elementos moveis

Legal Events

Date Code Title Description
PUP Patent expired